Monsanto Loses Key Biotech Lawsuit In Europe

Law360, New York (December 3, 2003, 12:00 AM EST) -- Monsanto Co. has lost one patent battle over a key technology used in genetically modifying plants, but says litigation in the U.S. will clarify its intellectual property rights in a long-running dispute with German researchers, the St. Louis Post-Dispatch reported.

Last week, the European Patent Office issued a patent for

agrobacterium-transformation technology to the Max Planck Society, a German research organization. The society gave an exclusive license to Monsanto’s German competitor Bayer CropScience.

Agrobacterium transformation technology allows scientists to transfer a gene into a host plant's...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.